Several studies have confirmed that programmed cell death ligand 1 (PD-L1) targeting immune checkpoint inhibitors played an important role in the development of numerous tumors, and high PD-L1 expression was associated with poor clinical outcomes in patients with PCa (13). Here, CD274 is linked to posterior cortical atrophy.